期刊文献+

大肠癌中Survivin、PTEN、p16的表达及其临床意义 被引量:5

The Expression and Clinical Significance of Survivin,PTEN and p16 in Colorectai Cancer
下载PDF
导出
摘要 目的:探讨Survivin、PTEN、p16基因在大肠癌中的表达及其临床意义。方法:利用免疫组织化学SP法检测43例结直肠癌和12例正常结直肠粘膜组织中以上3种基因的表达产物。结果:43例结直肠癌组织中Survivin基因表达23例,癌旁正常直结肠组织中无Survivin基因的表达,Survivin的表达与结直肠癌的组织分型、浸润深度、Dukes'分期无明显相关性(P>0.05),与结肠癌的转移有相关性(P<0.05)。而PTEN,p16与大肠癌的分化程度、浸润深度、临床分期、淋巴结转移有关(P<0.05)。结论:Survivin、PTEN、p16的异常表达在大肠癌发生、发展过程中起重要作用,联合检测Survivin、PTEN、p16表达水平有可能作为反映大肠癌进展和预后的生物学指标。 Objective: To investigate the expression of survivin, PTEN and p16 in their coloncarcinoma and the clinical significance. Methods:Immunohistochemical SP method was used to detect the expression of 3 proteins in 12 cases of normal colon tissue and 43 cases of coloncarcinoma. Results: We found that survivin in tissues of 23 cases of coloncarcinoma had positive expression, survivin was not expressed in normal tissue, over expression of survivin had no relation with histological type and Dukes classification,but it had obviously association with lymph node metastasis (P〈0. 05) ,the expression of PTEN and p16 were correlated with histological type,Dukes classification and lymph node metastasis. Conclusion: Abnormal expression of survivin, PTEN and p16 play an important role in occurrence and progression of large intestin carcinoma, associating survivin with PTEN and p16 may be amolecular-biological indicator in forecasting the progress and prognosis of colorectal carcinoma.
出处 《中国临床医学》 北大核心 2007年第1期31-32,共2页 Chinese Journal of Clinical Medicine
关键词 结直肠癌 SURVIVIN PTEN P16 免疫组织化学 Colorectal carcinoma Survivin PTEN p16 Immunohistochemistry
  • 相关文献

参考文献6

  • 1Kamb A,Cruis NA,Weaver-Feldhaus J,et al.A Cell cycle reyulator potentially involved in genesis of many tumor types[J].Science,1994,264:436.
  • 2Serrano M,Hannon GJ,Beach DA new regulatory motifin cell cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366:704.
  • 3Grabowski P.Prognostic value of nuclear surviving in expression in esophageal squamovs cell carcinoma[J].Br J Cancer,2003,88(1):115-119.
  • 4Tolkacheva T,Chan AM.Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene[J].Oncogene,2000,19(5):530-539.
  • 5LOKW,Cheung ST,Leung SP,et al.Hypermethulation of the p16 gene in nasophearyngeal carcinoma[J].Cancer Res,1996,56:2721.
  • 6汪学非,孙益红,左青松,卢韶华,秦新裕.胃癌组织中survivin表达与p53突变之间的初步分析[J].中国临床医学,2005,12(3):438-439. 被引量:2

二级参考文献6

  • 1Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[J]. Nat Med, 1997, 3(8):917-921.
  • 2LaCasse EC, Baird S, Korneluk RG. The inhibitors of apoptosis (IAPs) and their emerging role in cancer[J]. Oncogene, 1998,17 : 3247-3259.
  • 3Altieri DC, Marchisio PC, Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer[J]. Lab Invest.1999, 79:1327-1333.
  • 4Kawasaki H, et al. Expression of survivin correlates with apoptosis,proliferation, and angiogenesis during human colorectal tumorigenesis[J]. Cancer, 2001,1 ( 11 ) : 2026-2032.
  • 5Hoffman WH, Blade S, Zilfou JT, et al. Transcriptional repression of the antiapoptotic survivin gene by wild type p53[J]. J Biol Chem,2002, 277(5): 347-357.
  • 6Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53 dependent apoptotic pathway[J]. Oncogene, 2002, 21(17): 2613-2622.

共引文献1

同被引文献33

  • 1高再荣,张凯军,张永学.MAG_3和DTPA用于^(99)Tc^m标记Survivin ASON的对比研究[J].中华核医学杂志,2004,24(4):238-241. 被引量:5
  • 2Jian-Min Lei-MinSun Yu-JingFan Liang-JingWang.Trial of a novel endoscopic tattooing biopsy forceps on animal model[J].World Journal of Gastroenterology,2005,11(12):1859-1861. 被引量:14
  • 3徐少婷,郑艳,滕晓东,苏玲娣.p16^(INK4)、p21^(ras)及p185^(C-erbB-2)蛋白在子宫内膜癌的表达及临床病理意义[J].实用妇产科杂志,2005,21(4):220-222. 被引量:6
  • 4吕庆杰,赵晓东,宋继谒,李晓晗,马颖,孟辉,姜卫国.卵巢癌PTEN基因失活机制的探讨[J].中华病理学杂志,2005,34(5):266-269. 被引量:15
  • 5Sun H, Enomoto T, Fujita M, et al. Mutational analysis of thePTEN gene in endometrial carcinoma and hyperplasia [ J ]. Am J Clin Pathol,2001,115 :32-38.
  • 6Chu EC,Tarnawski AS. PTEN regulatory functions in tumor suppression and cell biology Med[ J]. Sci Monut,2004,10 (10) :235-241.
  • 7Minaguchi T,Yoshikawa H,Oda K,et al. PTEN mutation locatedonly outside exons 5,6 AND 7 is an independ-ent predictor of favorable survival in endometrial carcinomas [ J] Clin Cancer Res,2001,7: 2636 -2642.
  • 8Han SY,Kato H, KatoS,et al. Function evaluation of PTEN missense mutations using in viro phosphoinositide phosphatase assay[J]. Cancer Res,2006,60(12) :3147-3151.
  • 9Cerezo L,Cardenes H,Michael H. Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic imp lications [ J ]. Clin TrainsOncol,2006,8 (4) : 231-241.
  • 10Tamuram G J, MatsumotoK, AotaS, et al. lnhibltion of migration, spreading, and adhensions by tumer suppressor PTEN [ J ]. Science, 2004,280 (5369) : 1614-1617.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部